Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5391346
Reference Type
Journal Article
Title
Estimation in the progressive illness-death model: A nonexhaustive review
Author(s)
Meira-Machado, L; Sestelo, M
Year
2019
Is Peer Reviewed?
Yes
Journal
Biometrical Journal
ISSN:
0323-3847
EISSN:
1521-4036
Volume
61
Issue
2
Page Numbers
245-263
Language
English
PMID
30457674
DOI
10.1002/bimj.201700200
Web of Science Id
WOS:000460326200002
Abstract
Multistate models can be successfully used for describing complex event history data, for example, describing stages in the disease progression of a patient. The so-called "illness-death" model plays a central role in the theory and practice of these models. Many time-to-event datasets from medical studies with multiple end points can be reduced to this generic structure. In these models one important goal is the modeling of transition rates but biomedical researchers are also interested in reporting interpretable results in a simple and summarized manner. These include estimates of predictive probabilities, such as the transition probabilities, occupation probabilities, cumulative incidence functions, and the sojourn time distributions. We will give a review of some of the available methods for estimating such quantities in the progressive illness-death model conditionally (or not) on covariate measures. For some of these quantities estimators based on subsampling are employed. Subsampling, also referred to as landmarking, leads to small sample sizes and usually to heavily censored data leading to estimators with higher variability. To overcome this issue estimators based on a preliminary estimation (presmoothing) of the probability of censoring may be used. Among these, the presmoothed estimators for the cumulative incidences are new. We also introduce feasible estimation methods for the cumulative incidence function conditionally on covariate measures. The proposed methods are illustrated using real data. A comparative simulation study of several estimation approaches is performed and existing software in the form of R packages is discussed.
Tags
PFAS
•
PFAS 150
Literature Search Update December 2020
PubMed
Literature Search August 2019
PubMed
Web of Science
Not prioritized for screening
Sevoflurane
1,1,1,3,3,3-Hexafluoro-2- (fluoromethoxy)propane
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity